Related Experiment Videos
Central anticholinergic syndrome in anesthetic practice
Acta Anaesthesiologica Belgica
|January 1, 1976
Summary
Anticholinergic agents can cause Central Anticholinergic Syndrome (CAS), with symptoms like confusion and memory loss. Physostigmine salicylate effectively treated 200 CAS cases and related hyperpyrexia.
Area of Science:
- Anesthesiology
- Clinical Pharmacology
Background:
- Anticholinergic agents are widely used but can induce Central Anticholinergic Syndrome (CAS).
- CAS is characterized by cognitive and neurological symptoms, including impaired thought, memory disturbance, hallucinations, ataxia, and altered consciousness.